LKB1 Polyclonal Antibody

STK11 (serine/threonine kinase 11), which encodes a member of the serine/threonine kinase family, regulates cell polarity and functions as a tumor suppressor. Mutations in STK11 have been associated with Peutz-Jeghers syndrome, an autosomal dominant disorder characterized by the growth of polyps in the gastrointestinal tract, pigmented macules on the skin and mouth, and other neoplasms. Alternate transcriptional splice variants of STK11 have been observed but have not been thoroughly characterized.

The LKB1 Polyclonal Antibody is a highly specific and sensitive antibody designed for the detection of LKB1 protein in various biological samples. This antibody is produced using high-quality polyclonal antibodies that have been purified and validated for use in a wide range of applications, including Western blotting, immunohistochemistry, and immunofluorescence.

The LKB1 Polyclonal Antibody is a valuable tool for researchers studying the role of LKB1 in various cellular processes, including cell growth, differentiation, and metabolism. This antibody has been extensively tested and validated for its specificity and sensitivity, ensuring accurate and reliable results in a variety of experimental settings.

With its high specificity and sensitivity, the LKB1 Polyclonal Antibody is an essential tool for researchers working in the fields of cancer biology, cell signaling, and metabolic disorders. This antibody is available in a range of sizes and formats to suit the needs of different research applications, making it a versatile and valuable addition to any laboratory.